L. Jr and T. , Clonal diseases of large granular lymphocytes, Blood, vol.82, pp.1-14, 1993.

L. Jr, T. Kadin, M. Starkebaum, G. Abkowitz, J. Clark et al., Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia, Ann Intern Med, vol.102, pp.169-175, 1985.

L. Sokol, L. Jr, and T. , Large Granular Lymphocyte Leukemia, The Oncologist, vol.11, issue.3, pp.263-273, 2006.
DOI : 10.1634/theoncologist.11-3-263

T. Lamy, L. Jr, and T. , Clinical features of large granular lymphocyte leukemia, Seminars in Hematology, vol.40, issue.3, pp.185-195, 2003.
DOI : 10.1016/S0037-1963(03)00133-1

A. Jerez, M. Clemente, H. Makishima, A. Van-adrichem, H. Kuusanmäki et al., STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia, Blood, vol.120, issue.15, pp.3048-3057, 2012.
DOI : 10.1182/blood-2012-06-435297

H. Koskela, S. Eldfors, P. Ellonen, H. Koskela, F. Leblanc et al., Mutations in Large Granular Lymphocytic Leukemia, New England Journal of Medicine, vol.366, issue.20, pp.1905-1913, 2012.
DOI : 10.1056/NEJMoa1114885

A. Kern, W. Grossmann, V. Haferlach, C. Haferlach, T. Schnittger et al., STAT3 mutations are highly specific for large granular lymphocytic leukemia, Leukemia, vol.27, pp.1598-1600, 2012.

H. Rajala, S. Eldfors, H. Kuusanmaki, A. Van-adrichem, T. Olson et al., Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia, Blood, vol.121, issue.22, pp.4541-4550, 2013.
DOI : 10.1182/blood-2012-12-474577

A. Teramo, C. Gattazzo, F. Passeri, A. Lico, G. Tasca et al., Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia, Blood, vol.121, issue.19, pp.3843-3854, 2013.
DOI : 10.1182/blood-2012-07-441378

L. Jr, T. Kidd, P. Starkebaum, and G. , Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate, Blood, vol.84, pp.2164-2170, 1994.

R. Go, C. Li, A. Tefferi, and R. Phyliky, Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes, Blood, vol.98, issue.2, pp.483-485, 2001.
DOI : 10.1182/blood.V98.2.483

N. Fujishima, K. Sawada, M. Hirokawa, K. Oshimi, K. Sugimoto et al., Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group, Haematologica, vol.93, issue.10, pp.1555-1559, 2008.
DOI : 10.3324/haematol.12871

B. Bareau, J. Rey, M. Hamidou, J. Donadieu, J. Morcet et al., Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases, Haematologica, vol.95, issue.9, pp.1534-1541, 2010.
DOI : 10.3324/haematol.2009.018481
URL : https://hal.archives-ouvertes.fr/hal-00744223

T. Lamy, L. Jr, T. Semenzato, G. Zambello, R. Starkebaum et al., How I treat LGL leukemia, Blood, vol.117, issue.10, pp.2764-2774, 1997.
DOI : 10.1182/blood-2010-07-296962
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062292

W. Morice, P. Kurtin, A. Tefferi, and C. Hanson, Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B, Blood, vol.99, issue.1, pp.268-274, 2002.
DOI : 10.1182/blood.V99.1.268

M. Dhodapkar, C. Li, J. Lust, A. Tefferi, and R. Phyliky, Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance, Blood, vol.84, pp.1620-1627, 1994.

S. Mohan, M. Clemente, M. Afable, H. Cazzolli, N. Bejanyan et al., Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia, Haematologica, vol.94, issue.10, pp.1407-1414, 2009.
DOI : 10.3324/haematol.2009.009191

L. Jr, T. Yao, X. Bennett, J. Litzow, M. Evens et al., Results of a prospective multicenter phase ii study of initial treatment with methotrexate in LGL leukemia (ECOG Protocol E5998), ASH Annual Meeting Abstracts, vol.116, p.702, 2010.